908 Devices Inc. (MASS) research
908 Devices Inc.- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $12.69
- As of
908 Devices Inc. (MASS): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-11.
As of . Source: SEC EDGAR filings for MASS. Method and limitations.
Share the MASS intelligence card
See the full MASS dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for MASS on one page. Preview it with sample data, then open it live with a free account.
Preview the MASS dossierActive signals for MASS
- highINSTITUTIONAL_SURGE
D. E. Shaw & Co., Inc. added +195% to MASS (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 36.6%, EPS $-0.11 vs $-0.1734 estimate
- mediumEARNINGS_MISS
Q3-2025: Missed consensus by 136.4% - EPS $-0.41 vs $-0.1734 estimate
- mediumEARNINGS_BEAT
Q4-2025: Beat consensus by 240.1% - EPS $0.1 vs $-0.0714 estimate
- mediumEARNINGS_MISS
Q1-2026: Missed consensus by 100.3% - EPS $-0.32 vs $-0.1598 estimate
FREE, NO ACCOUNT
Every signal on MASS, as it fires
New filings, 13F moves and cross asset signals on MASS land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in MASS (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 65443P102 · 2026Q2 | $1.7M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 65443P102 · 2026Q2 | $656K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 65443P102 · 2026Q2 | $546K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, MASS
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
MASS against its peers
MASS's operating margin of -70.1% ranks in the 25th percentile of 21 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2025-12-31.
| Metric | MASS | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 56.2M USD | 100.0M USD | 30 | 21 |
| Gross margin | 50.6% | 70.9% | 21 | 20 |
| Operating margin | -70.1% | -33.7% | 25 | 21 |
| Net margin | 34.7% | -41.5% | 98 | 21 |
| Return on equity | 13.6% | -33.1% | 93 | 20 |
| P / E | 23.5x | n/a | n/a | 3 |
Peers (22): SENS, DCTH, TCMD, KIDS, SSII, NPCE, QDEL, OFIX, RCEL, CLPT, VMD, QSI, CV, INMD, SIBN, CATX, CBLL, LAB, TMCI, BBNX, TLSI, ENOV. Left out: BWAY (period gap), MOBI (no annual filing), LMRI (no annual filing). Fiscal periods ending between 2025-12-28 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (MASS: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more MASS signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to MASSand get the insider, 13F, options, and confluence read in one view.